THC concentrates, commonly known as dabs, wax, shatter, budder, or distillate, contain 60 to 90% THC compared to 15 to 25% in typical cannabis flower. This 3 to 6 fold potency increase fundamentally changes the risk profile: faster tolerance development, more severe dependence, more intense withdrawal, higher rates of cannabis-induced psychosis, and greater cardiovascular and pulmonary risks. The rapid rise in concentrate use, particularly among younger users, represents a significant shift in the cannabis landscape that existing research on lower-potency cannabis does not fully capture.
Clinically reviewed by Dr. Ponlawat Pitsuwan, Physician, Phuket Island Rehab
“The patients presenting to Phuket Island Rehab with concentrate dependence often describe a pattern of escalation that mirrors what we see with more traditionally recognised drugs of abuse,” says Dr. Ponlawat Pitsuwan. “They began with flower, found it insufficient, graduated to concentrates, and within months were dabbing multiple times daily with a tolerance that flower could no longer touch. The withdrawal they experience is more severe than what we typically see with flower-only users, and the psychological dependence pattern is more entrenched.”
What THC Concentrates Are
THC concentrates are produced by extracting and concentrating the psychoactive compounds from cannabis plant material. Several extraction methods produce different concentrate forms. Butane hash oil (BHO) extraction uses butane as a solvent to strip trichomes from plant material, producing wax, shatter, budder, or crumble depending on post-processing technique. CO2 extraction uses supercritical carbon dioxide and is considered cleaner, producing oils and distillates. Rosin is produced through heat and pressure without chemical solvents. Distillate, the most refined form, can reach 95% or higher THC purity.
These concentrates are consumed through “dabbing,” which involves placing a small amount of concentrate onto a heated surface (a “nail” or “banger,” typically quartz, titanium, or ceramic) attached to a water pipe, then inhaling the resulting vapour. Electronic devices such as dab pens and concentrate vaporisers provide portable alternatives. The inhalation route delivers high-concentration THC to the lungs, where it passes rapidly into the pulmonary vasculature and reaches the brain within seconds, producing an onset speed comparable to smoking crack cocaine rather than the more gradual onset of smoking flower.
Potency Comparison
| Product | Typical THC Content | Relative Dose Per Inhalation | Dependence Risk |
|---|---|---|---|
| Cannabis flower (1990s average) | 3 to 5% | Baseline | Moderate with daily use |
| Cannabis flower (current average) | 15 to 25% | 3 to 5x baseline | Elevated with daily use |
| Wax / budder / crumble | 60 to 80% | 12 to 16x baseline | High; rapid tolerance development |
| Shatter | 70 to 90% | 14 to 18x baseline | High; severe withdrawal reported |
| Distillate | 85 to 95%+ | 17 to 19x baseline | Very high; most severe dependence profile |
Why Concentrates Accelerate Dependence
The dose-response relationship between THC exposure and CB1 receptor downregulation is fundamental. Higher THC concentrations produce greater receptor activation, which triggers more aggressive compensatory downregulation by the brain. A daily concentrate user is exposing their CB1 receptors to THC loads that are orders of magnitude higher than the cannabis use patterns studied in most historical research. This accelerated downregulation produces faster tolerance, deeper dependence, and more severe withdrawal.
The speed of onset also intensifies reinforcement. Like the pharmacokinetic difference between snorting powder cocaine and smoking crack, the near-instantaneous delivery of high-dose THC from dabbing produces a more intense “rush” than smoking flower. Faster onset equals stronger positive reinforcement, which accelerates the habit formation that underlies compulsive use. Concentrate users frequently report that they cannot return to flower because it no longer produces perceptible effects, a sign of profound tolerance driven by the extreme receptor activation that concentrates provide.
Warning: Home production of BHO concentrates using butane is extremely dangerous. Butane is heavier than air, accumulates at floor level, and can be ignited by any spark source. Explosions and severe burns during home BHO extraction have resulted in numerous injuries and deaths. This is not a safe DIY activity regardless of ventilation precautions.
Health Risks Specific to Concentrates
Beyond the accelerated dependence risk, concentrates introduce specific health concerns. Pulmonary injury from dabbing at high temperatures can cause thermal damage to airway epithelium. The EVALI (e-cigarette or vaping product use associated lung injury) outbreak in 2019 was linked to vitamin E acetate used as a diluent in THC vape cartridges, causing lipoid pneumonia and acute respiratory distress. While regulated markets have largely eliminated vitamin E acetate, unregulated and black-market products remain a risk.
Residual solvents in improperly purged BHO concentrates (butane, propane, hexane) can cause respiratory irritation and potential neurotoxicity with chronic exposure. The high-temperature dabbing process itself can produce harmful degradation products including methacrolein and benzene from terpene decomposition, particularly when concentrates are applied to surfaces heated above 600°F (315°C). Low-temperature dabbing (below 400°F) reduces but does not eliminate these risks.
The psychosis risk associated with high-potency cannabis appears to be dose-dependent, meaning concentrates represent the highest-risk category. While direct epidemiological studies specifically on concentrate-associated psychosis are still emerging, the established dose-response relationship between THC potency and psychosis risk strongly suggests that daily concentrate use carries greater psychosis risk than daily flower use.
Clinical insight: Concentrate-dependent patients at Phuket Island Rehab typically experience more severe cannabis withdrawal than flower-only users, with more intense insomnia, more pronounced irritability and agitation, longer duration of anhedonia, and stronger craving. Medical management during withdrawal may need to be adjusted accordingly, and patients should be prepared for a potentially more difficult first two weeks.
When Substance Use Has Become More Than Occasional
If your cannabis use has escalated from flower to concentrates, if you dab multiple times daily, if flower no longer produces effects, if you experience significant withdrawal symptoms when you stop, or if your concentrate use is interfering with your daily functioning, relationships, or goals, these patterns indicate a level of cannabis dependence that warrants clinical attention. The potency of concentrates means that dependence develops faster and is more severe than with traditional cannabis, and the withdrawal can be correspondingly more challenging to manage without support.
Residential treatment provides the ideal environment for concentrate cessation because it removes access to the substance, provides medical oversight during withdrawal, and offers the therapeutic programming to address the psychological patterns that sustain use. At Phuket Island Rehab, patients with concentrate dependence receive the same evidence-based treatment framework as any substance use disorder, adapted to the specific characteristics of high-potency cannabis dependence.
Summary
THC concentrates represent a fundamentally different product category from traditional cannabis flower, with THC concentrations 3 to 6 times higher. This potency escalation accelerates tolerance, deepens dependence, intensifies withdrawal, and increases mental health risks including psychosis. Additional health risks include pulmonary damage, residual solvent exposure, and thermal degradation products. The pattern of escalating from flower to concentrates mirrors the pharmacological progression seen with other substance classes and warrants the same clinical seriousness.
“When a patient tells me they need to dab every two hours to function, we are no longer talking about recreational cannabis use,” says Dr. Ponlawat Pitsuwan. “We are talking about a substance use disorder driven by extremely high-dose THC exposure that has profoundly altered their endocannabinoid system. The treatment approach is the same as for any other substance dependence: medically supported withdrawal, therapeutic intervention to address the underlying drivers, and the development of sustainable recovery skills. The endocannabinoid system recovers, but it needs time and the right conditions.”
Frequently Asked Questions
Are dabs more dangerous than smoking flower?
Yes, in several measurable ways. Concentrates deliver 3 to 6 times more THC per inhalation, produce faster and more severe dependence, create more intense withdrawal, carry higher psychosis risk due to dose-response effects, and introduce additional pulmonary risks from high-temperature inhalation and potential residual solvents. The relationship between potency and risk is well established, and concentrates sit at the extreme end of the potency spectrum.
Can you get addicted to dabs faster than flower?
Yes. Higher THC concentrations produce more rapid CB1 receptor downregulation and tolerance development. Users who begin with concentrates or transition to them typically report a faster trajectory from controlled use to compulsive daily use compared to flower-only users. The faster onset of smoked/vaporised concentrates also strengthens the reinforcement learning that underlies habit formation and compulsive use patterns.
What is EVALI and is it still a concern?
EVALI (e-cigarette or vaping product use associated lung injury) was an outbreak in 2019 linked primarily to vitamin E acetate used as a diluent in illicit THC vape cartridges. Over 2,800 hospitalisations and 68 deaths were reported. Regulated markets have largely eliminated vitamin E acetate, but unregulated and black-market THC vape cartridges remain a concern. Products obtained outside licensed dispensaries cannot be assumed safe from contamination.
Is dabbing at lower temperatures safer?
Low-temperature dabbing (below 400°F / 204°C) produces fewer harmful thermal degradation products (such as benzene and methacrolein) than high-temperature dabbing. However, lower temperature does not reduce the THC dose delivered, the dependence risk, the withdrawal severity, or the psychosis risk. It addresses one category of harm (pulmonary toxicity from degradation products) while leaving the primary risks unchanged.
Can I switch back to flower if concentrates are a problem?
Many concentrate-dependent users find that flower no longer produces perceptible effects due to the extreme tolerance that concentrates have created. If switching to flower is possible, it would reduce THC exposure and allow some receptor recovery. However, switching to a lower-potency version of the same substance is rarely a sustainable solution for dependence; the more effective clinical approach is addressing the cannabis use disorder itself through abstinence-supported treatment.
Are “live resin” and “live rosin” safer than BHO?
Live resin and live rosin are extraction methods that preserve more of the plant’s terpene profile. Live rosin, produced through heat and pressure without chemical solvents, eliminates the residual solvent concern associated with BHO. Live resin, which uses hydrocarbon solvents, carries the same residual solvent concerns as other BHO products. Neither product is “safer” in terms of THC concentration or dependence risk; both typically contain 60 to 85% THC and carry the same high-potency risk profile regardless of extraction method.
Sources
Centers for Disease Control and Prevention. “Outbreak of Lung Injury Associated with the Use of E-Cigarette, or Vaping, Products.” cdc.gov
National Institute on Drug Abuse (NIDA). “Marijuana Concentrates DrugFacts.” National Institutes of Health. drugabuse.gov
Meehan-Atrash J, et al. “Toxicant formation in dabbing: the terpene story.” ACS Omega. 2017;2(9):6112-6117.
THC concentrates · Dabs · Wax · Shatter · Budder · Distillate · Live resin · Live rosin · BHO · CB1 receptor · Endocannabinoid system · EVALI · Vitamin E acetate · Benzene · Methacrolein · Cannabis use disorder · Phuket Island Rehab